newsfilter
← Latest News
PR Newswire·

Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update

Multiple clinical data readouts expected in second half of 2022 LOS GATOS, Calif., May 16, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective the